Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical Submits Biodefense Contract Proposal to U.S. Government
June 18th, 2008
Aethlon Medical, Inc. (OTCBB:AEMD) announced that it has submitted a contract proposal to a Broad Agency Announcement (BAA) solicitation entitled; "Application of Platform Technologies for the Development of Therapeutic Agents for Biodefense." The solicitation (DMID-NIAID-NIHAI20080022BARDA) represents a partnership between the National Institute of Allergy and Infectious Diseases (NIAID) and the recently established Biomedical Advanced Research and Development Authority (BARDA) to award contracts that fund the development of innovative approaches to treat bioterror and emerging pandemic threats. "We are proud of the contract response provided to NIAID and BARDA and...
Source: Vaccine Weekly (2008-06-18)
|
